Vitro Scient Limited Partnership of Cairo at MEDICA 2017 in Düsseldorf -- COMPAMED Trade Fair

Vitro Scient Limited Partnership

P.O. Box 499, 11757 Cairo
62 El Montazah St. Heliopolis, 11351 Cairo
Egypt

Telephone +20 2643 9698
Fax +20 2643 9699
info@vitroscient.com

This company is co-exhibitor of
Egypt Expo & Convention Authority (EECA)

Hall map

MEDICA 2017 hall map (Hall 3): stand G66

Fairground map

MEDICA 2017 fairground map: Hall 3

Our range of products

Product categories

  • 03  Diagnostics
  • 03.03  Haematology / Histology / Cytology
  • 03.03.09  Immunohaematology (Blood grouping)

Our products

Product category: Immunohaematology (Blood grouping)

Anti – A

Monoclonal antibodies are derived from hybridoma cell lines, created by fusing mouse antibody producing B lymphocytes with mouse myeloma cells. Each hybridoma cell line produces homogenous antibodies of only one immunoglobulin class, which are identical in their chemical structure and immunological activity.

Human red blood cell antigens can be divided into four groups A, B, AB and O depending on the presence or absence of the corresponding antigens on the red blood cells.

Approximately 41% of the Caucasian population have the A Antigen, 9% have the B Antigen, 4% have both A and B antigens, while the remaining have neither the A nor the B antigen.

More Less

Product category: Immunohaematology (Blood grouping)

Anti – AB

Monoclonal antibodies are derived from hybridoma cell lines, created by fusing mouse antibody producing B lymphocytes with mouse myeloma cells. Each hybridoma cell line produces homogenous antibodies of only one immunoglobulin class, which are identical in their chemical structure and immunological activity.

Human red blood cell antigens can be divided into four groups A, B, AB and O depending on the presence or absence of the corresponding antigens on the red blood cells.

Approximately 41% of the Caucasian population have the A Antigen, 9% have the B Antigen, 4% have both A and B antigens, while the remaining have neither the A nor the B antigen.

More Less

Product category: Immunohaematology (Blood grouping)

Anti – B

Monoclonal antibodies are derived from hybridoma cell lines, created by fusing mouse antibody producing B lymphocytes with mouse myeloma cells. Each hybridoma cell line produces homogenous antibodies of only one immunoglobulin class, which are identical in their chemical structure and immunological activity.

Human red blood cell antigens can be divided into four groups A, B, AB and O depending on the presence or absence of the corresponding antigens on the red blood cells.

Approximately 41% of the Caucasian population have the A Antigen, 9% have the B Antigen, 4% have both A and B antigens, while the remaining have neither the A nor the B antigen.

More Less

Product category: Immunohaematology (Blood grouping)

Anti – D IgG & IgM

Monoclonal antibodies are derived from hybridoma cell lines, created by fusing mouse antibody producing B lymphocytes with mouse myeloma cells or are derived from a human cell line through EBV transformation. Each hybridoma cell line produces homogenous antibodies of only one immunoglobulin class, which are identical in their chemical structure and immunological activity.

Human red blood cells are classified as Rho (D) positive and Rho (D) negative depending upon the presence or absence of D (Rho) antigen on them. Approximately 85% of the Caucasian population are Rho (D) positive. The Du phenotype is a traditional definition to describe the weak / partial D’s that can be detected with Anti-D (Rho) (IgM+IgG). About 60% of the Du (weak / partial D’s) may react with Anti-D (Rho) (IgM+IgG) in slide tests and about 90% may be detected by tube technique.

More Less

About us

Company details

Building on more than 20 years of innovation and experience, Vitro scient is a technology driven-fast growing company focusing on providing highly reliable quality assays through research, development, manufacturing and marketing of in vitro diagnostics. Vitro glucose reagent combines the use of glucose oxidase enzymes with the peroxidase/phenol / 4-aminoantipyrine system of Trinder for the measurement of glucose in human serum, urine, or CSF. Although many technological advances to diagnostic reagents have been implemented to improve reagent stability specially for liquid stable reagents (LS). However, these LS reagents failed to fulfil conformity criteria due to: Enzyme deterioration over storage period. Spontaneous coloration over storage period Interferences from lipids, bilirubin and hemoglobin. Enzymax is a solution rather than a new line of reagents with unsurpassed stability. The continuous effort of Vitro Scient R&D researchers has succeeded to launch ENZYMAX reagents having the power to resist all causes of enzyme and reagent deterioration. In the same time an unrivaled combination of surfactants and interference inhibitors have totally eliminated the undesired effects of lipidemia, hyperbilirubinemia and hemolysis.

More Less